Monitor your health while on a weight-loss journey with our At-Home GLP-1 Weight Management Health Panel. Designed for individuals using GLP-1 medications (such as Ozempic®, Wegovy®, Mounjaro®) or following structured weight-management programmes, this test tracks key markers related to treatment safety, metabolic balance, and overall wellbeing. This comprehensive panel measures: Blood sugar control: HbA1c Liver & pancreatic health: ALT, AST, GGT, Bilirubin, Amylase, Lipase Kidney function: Urea, Creatinine, Uric Acid, eGFR Thyroid balance: TSH, Free T4 (FT4) Cholesterol & lipids: Total Cholesterol, HDL, LDL, Triglycerides Full Blood Count (FBC): To assess immunity, anaemia and overall health Ideal for individuals on GLP-1 medications, in medical or nutrition-led weight-loss programmes, or anyone wanting to track metabolic health, treatment response, and safety markers over time.
GLP-1 receptor agonists (such as semaglutide, liraglutide and tirzepatide), used alongside structured weight-loss programmes, can significantly improve weight management, appetite control, and blood sugar regulation. To ensure safe and effective treatment, regular monitoring is essential.
The Weight Loss / GLP-1 Profile from Vitalync Diagnosis checks the key systems affected by GLP-1 therapy and weight loss, helping you and your clinician track progress, detect early issues, and optimise results safely.
HbA1c — Shows your 2–3 month average blood glucose levels; vital for monitoring diabetes, pre-diabetes and metabolic improvements.
ALT, AST, GGT, Total Bilirubin — Assess liver function, bile flow and inflammation.
Amylase, Lipase — Pancreatic enzymes; raised levels may indicate irritation, pancreatitis or medication-related stress.
Urea, Creatinine, Uric Acid, eGFR — Core kidney markers to ensure hydration and medication safety, especially during rapid weight loss.
TSH, Free T4 (FT4) — Thyroid function influences metabolism, energy, weight loss and response to GLP-1 therapy.
Total Cholesterol, HDL, LDL, Triglycerides — Track heart health and cardiovascular risk as weight and metabolic markers change.
Full Blood Count (FBC) — Screens for anaemia, infection or immune changes that may impact energy, recovery, and resilience during weight loss.
This test is ideal for:
People using (or considering) GLP-1 medications for weight loss or type 2 diabetes
Individuals managing obesity, metabolic syndrome, pre-diabetes or type 2 diabetes
Anyone on a medical, nutrition-led or intensive weight-loss programme wanting baseline and progress tracking
Those experiencing fatigue, weight fluctuations or metabolic symptoms needing structured review
People seeking a safe, measurable and informed weight-loss journey
This profile provides a full picture of how your body is responding to GLP-1 therapy and lifestyle change by:
Flagging potential safety or side-effect concerns early
Confirming positive metabolic and cardiovascular improvements
Monitoring liver, kidney and pancreatic function for treatment safety
Supporting clinician-led adjustments to medication, nutrition, hydration or exercise
Helping you achieve safer, healthier, long-term weight-loss outcomes
Order online in minutes
Visit your nearest Vitalync Diagnosis partner blood draw clinic (no GP referral required)
Post your sample to our UK-accredited laboratory using the prepaid pack
Receive your results securely online via email
Morning sampling and fasting may be advised for optimum accuracy (especially lipids).
If you are on GLP-1 therapy or other medication, follow the timing guidance included.
Results support assessment and monitoring but should be reviewed with a healthcare professional.
GLP-1 receptor agonists (such as semaglutide, liraglutide, and tirzepatide) together with structured weight-loss programmes can transform both weight management and glucose control. But safe and effective treatment requires smart monitoring.
The Weight Loss / GLP-1 Profile from Vitalync Diagnosis checks the key systems affected by weight loss and GLP-1 therapy, helping you and your clinician track progress, detect early issues, and optimise results safely.
HbA1c — Provides a 2–3 month average of blood sugar levels; crucial for diabetes and pre-diabetes monitoring.
ALT, AST, GGT, Total Bilirubin — Assess liver function and detect stress or bile flow issues.
Amylase, Lipase — Pancreatic enzymes; raised levels may signal inflammation or irritation.
Urea, Creatinine, Uric Acid, eGFR — Core kidney health markers ensuring therapy safety and good hydration.
TSH, Free T4 (FT4) — Thyroid balance influences energy, weight regulation, and response to GLP-1 therapy.
Total Cholesterol, HDL, LDL, Triglycerides — Track cardiovascular risk factors as weight and metabolism change.
Full Blood Count (FBC) — Screens for anaemia, infection, or immune changes that may affect energy, recovery, or resilience.
People using or considering GLP-1 medications for weight loss or type 2 diabetes
Individuals managing obesity, pre-diabetes, or type 2 diabetes
Anyone undertaking intensive diet or exercise programmes who wants baseline and progress checks
Those experiencing fatigue, weight fluctuations, or metabolic symptoms and seeking structured review
This profile provides a comprehensive overview of how your body is adapting to treatment and lifestyle change by:
Order online in minutes
Visit your nearest Vitalync Diagnosis partner blood draw clinic for professional sample collection (no referral needed)
Post your kit back to our accredited UK laboratory using the prepaid pack
Receive results securely online, via email
Morning sampling and fasting may be recommended (particularly for lipid testing).
If you’re on GLP-1 therapy or other medication, always follow the timing instructions provided.
Results support assessment and should be interpreted by a healthcare professional.